Found: 11
Select item for more details and to access through your institution.
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 1, p. 93, doi. 10.1007/s00432-007-0254-5
- By:
- Publication type:
- Article
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression.
- Published in:
- Respirology, 2021, v. 26, n. 5, p. 461, doi. 10.1111/resp.13988
- By:
- Publication type:
- Article
Glial fibrillary acidic protein: A marker of axonal Guillain-Barrè syndrome and outcome.
- Published in:
- Muscle & Nerve, 2008, v. 38, n. 1, p. 899, doi. 10.1002/mus.20983
- By:
- Publication type:
- Article
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.
- Published in:
- 2016
- By:
- Publication type:
- research
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 4, p. 1173, doi. 10.1007/s10067-019-04922-6
- By:
- Publication type:
- Article
CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: a meta-analysis of the literature.
- Published in:
- Carcinogenesis, 2007, v. 28, n. 1, p. 101, doi. 10.1093/carcin/bgl124
- By:
- Publication type:
- Article
Molecular Biomarkers in Interstitial Lung Diseases.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 5, p. 505, doi. 10.1007/s40291-014-0109-0
- By:
- Publication type:
- Article
Rituximab in severe, treatment-refractory interstitial lung disease.
- Published in:
- Respirology, 2014, v. 19, n. 3, p. 353, doi. 10.1111/resp.12214
- By:
- Publication type:
- Article
Review Series: Aspects of Interstitial lung disease: Connective tissue disease-associated interstitial lung disease: How does it differ from IPF? How should the clinical approach differ?
- Published in:
- Chronic Respiratory Disease, 2011, v. 8, n. 1, p. 53, doi. 10.1177/1479972310393758
- By:
- Publication type:
- Article
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-023-02589-x
- By:
- Publication type:
- Article